International Active Surveillance Study of Medication Used for the Treatment of Endometriosis: Visanne Post-approval Observational Study.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2018
At a glance
- Drugs Dienogest (Primary) ; Hormones
- Indications Endometriosis
- Focus Adverse reactions
- Acronyms VIPOS
- 24 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019.
- 24 Jan 2018 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2018.
- 30 Aug 2017 Results comparing safety and drug utilisation patterns of dienogest with other hormonal treatments, presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management.